Search
for
Sort by
Research 61–90 of 1000+
- Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Alefacept for Severe Alopecia Areata
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study.
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Alopecia areata: A review
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Serum vitamin D level is related to disease severity in pediatric alopecia areata
- Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis
- Evaluation of Serum Homocysteine, High-Sensitivity CRP, and RBC Folate in Patients with Alopecia Areata
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Platelet-Rich Plasma in Alopecia Areata—A Steroid-Free Treatment Modality: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- Role of Hair Prostheses (Wigs) in Patients with Severe Alopecia Areata
- Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- Rethinking the classification of alopecia areata
- Serum level of vitamin D in patients with alopecia areata
- Successful treatment of resistant alopecia areata with a phototoxic dose of ultraviolet A after topical 8‐methoxypsoralen application
- Janus Kinase Inhibitors for Alopecia Areata
- Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses